Thermogenesis Agreement For Cord Blood Systems With Umbilical Cord Stem Cells Company

By Author: Jackson daren
Total Articles: 80
Comment this article

Thermogenesis has recently announced agreement with the Beike, a Chinese stem cell company. Thermogenesis is among the top most supplier of the most innovative products and services dealing in storage of adult stem cells. Beike is the leading stem cell banking and regeneration company of China.

Thermogenesis Corp. -

Thermogenesis is the leader in developing and manufacturing of the blood processing systems and disposable products. Several systems it offers are-

• BioArchive system – It is a cryogenic device which is used for baby cord blood banking in more than thirty countries.

• AXP Autoexpress – They are those automated devices that include AXP and MXP and also blood processing for harvesting stem cells. AXP is used for cord blood processing

In addition to these, others are CryoSeal FS system and Res-Q systems.
Bekie Biotechnology Co. Ltd.-

Bekie has its headquarters in Shenzhen that is in China with its offices in several major cities of the country. The company is one of the most reputed biotechnology companies in stem cell ...
... therapies and cell banking. The scientists of the firm are highly dedicated to develop and commercialize stem cells therapies since the year 1999. However, banking operations were started in 2008. At present, the company produces stem cells obtained from bone marrow and cord blood tissue and also from private cord blood banking. It has three cord blood processing and storage units and five stem cells banks. There are eighteen laboratories for cord blood collection and two research laboratories for stem cells.

With the help of this agreement, Thermogenesis will supply stocks for the fiscal year 2011 of its AXP and BioArchive systems. As per CEO of Thermogenesis, the company is pleased with its agreement with Beike which is known to be a regenerative leader in the Chinese economy. The partnership further has opened new doors for the company to expand its share in the Chinese market. The company would also step into prospective sector of umbilical cord storage with advanced stem cell therapies. With the collaboration of the two companies, both will develop advanced technologies and maximize the automation of the process.

According to Beike’s CEO, AXP and BioArchive systems are the most important perspectives of the company’s strategy to become technology and quality king. It will become the first bank in China to have recognition for cord blood processing and storage. Compare cord blood banks all around the universe and one will find that Beike is among the topmost market players. This collaboration will be highly beneficial for both companies.

About the Author:

This article is written by Jackson daren this is having topics on baby cord blood banking, private cord blood banking, Compare cord blood banks and many more. For more: http://cryocell.blog.com/